Inventor · disambiguated record
Fu-An Kang
Also filed as: KANG FU-AN
7 granted patents·4 pending applications·4 citations·filing 2005–2024
74Inventor score
Top patents by PatentIndex Score
11 records- 0183US2025257074A1Synthetic processes and synthetic intermediatesTAXIS PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 0279US12173013B2Synthetic processes and synthetic intermediatesTAXIS PHARMACEUTICALS INC·Filed 2023·Granted Dec 24, 2024·0 cites·16 claims
- 0372US10774093B2Synthetic processes and synthetic intermediatesTAXIS PHARMACEUTICALS INC·Filed 2018·Granted Sep 15, 2020·1 cites·12 claims
- 0471US8822460B2Fused cyclopentyl antagonists of CCR2JANSSEN PHARMACEUTICA NV·Filed 2013·Granted Sep 2, 2014·2 cites·18 claims
- 0570US7763648B2Oxa-steroids derivatives as selective progesterone receptor modulatorsJANSSEN PHARMACEUTICA NV·Filed 2007·Granted Jul 27, 2010·1 cites·13 claims
- 0666US2021139508A1Synthetic processes and synthetic intermediatesTAXIS PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 0759US2025127912A1Compositions for delivery of polynucleotidesMIRECULE INC·Filed 2024·Application pending·0 cites
- 0855US11014940B1Thiazolidinone and oxazolidinone compounds and formulationsCELGENE CORP·Filed 2019·Granted May 25, 2021·0 cites·24 claims
- 0943US9024017B2Octahydro-cyclopentapyrrolyl antagonists of CCR2JANSSEN PHARMACEUTICA NV·Filed 2013·Granted May 5, 2015·0 cites·13 claims
- 1041US2005250945A1Triazine compounds as inhibitors of bacterial type III protein secretion systemsLI XIAOBING·Filed 2005·Application pending·0 cites
- 1135US10654873B2Cytotoxic agents and conjugates thereofPOLYTHERICS LTD·Filed 2017·Granted May 19, 2020·0 cites·32 claims
Join the waitlist — get patent alerts
Get an alert when Fu-An Kang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →